Taken together, these findings suggest that mutant p53 is directly bound to the promoter of the ALKBH5 region to inhibit its transcription, downregulated ALKBH5 protein level, and accelerated colorectal cancer progression. This evidence concerns the gene TP53 and colorectal cancer.